title: Bypass Angioplasty Revascularization Investigation: patient screening, selection, and recruitment.
abstract: Percutaneous transluminal coronary angioplasty (PTCA) is currently performed in many patients seeking care because of severe manifestations of multivessel coronary artery disease. Previously, the majority of such patients would have undergone coronary artery bypass grafting (CABG). No definitive evidence is available as to which initial revascularization strategy has the best long-term clinical and economic outcomes. The Bypass Angioplasty Revascularization Investigation (BARI) is the largest of several recent clinical trials that were designed to test the hypothesis that an initial strategy of PTCA in selected patients with multivessel coronary artery disease does not compromise long-term clinical outcome compared with an initial strategy of CABG. This report describes how patients were screened, selected, and recruited in BARI and how this process may influence the results and the interpretation of the trial. During the enrollment period, 25,200 patients undergoing diagnostic coronary angiography at the participating institutions or with off-site angiograms referred to BARI investigators were screened for BARI eligibility. Excluded from screening were patients without coronary artery disease, those with single-vessel disease, prior revascularization, primary congenital, valvular, or myocardial disease, and age > 80 years. Slightly more than half of the patients screened (12,670) were not clinically eligible for BARI because of left main disease, insufficient symptoms, emergency revascularization, or other logistic reasons. Thus, 12,530 patients had severe angina and/or ischemia and were clinically eligible for BARI. Nearly 33% of them (4,110) had multivessel disease, which was suitable for both PTCA and CABG.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Montreal Heart Institute, Quebec, Canada.
authors.forename: M G
authors.initials: MG
authors.lastname: Bourassa
authors.forename: G S
authors.initials: GS
authors.lastname: Roubin
authors.forename: K M
authors.initials: KM
authors.lastname: Detre
authors.forename: G
authors.initials: G
authors.lastname: Sopko
authors.forename: R J
authors.initials: RJ
authors.lastname: Krone
authors.forename: M J
authors.initials: MJ
authors.lastname: Attabuto
authors.forename: P
authors.initials: P
authors.lastname: Bjerregaad
authors.forename: S
authors.initials: S
authors.lastname: Bolling
authors.forename: M V
authors.initials: MV
authors.lastname: Herman
authors.forename: R
authors.initials: R
authors.lastname: Frye
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D002986:Clinical Trials as Topic; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000601:surgery*; D006801:Humans; D015337:Multicenter Studies as Topic; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic; D012042:Registries; D014481:United States